Study guide
12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis
Key Takeaways Explain This Topic AI
Acute angle-closure glaucoma is an ophthalmic emergency presenting with excruciating ocular pain, steamy cornea, fixed mid-dilated pupil, and rock-hard globe, treated immediately with topical pilocarpine, IV acetazolamide, and definitive bilateral laser iridotomy.
Anterior uveitis is strongly associated with HLA-B27 spondyloarthropathies, presenting with deep aching pain, photophobia, ciliary flush, and a sluggish or irregular pupil with cells and flare, treated with topical cyclopentolate and corticosteroids.
Microbial keratitis in contact lens wearers is frequently caused by Pseudomonas aeruginosa and must never be patched; herpes simplex dendritic ulcers require topical aciclovir, and topical corticosteroids are strictly contraindicated.
Orbital cellulitis is a post-septal surgical emergency presenting with proptosis, painful ophthalmoplegia, reduced visual acuity, and RAPD, distinguished from preseptal cellulitis which spares visual function and ocular mobility.
Last updated: October 2026
The Acute Red Eye: Glaucoma, Uveitis & Keratitis
The acute red eye is a common presenting complaint across acute medical, emergency, and primary care settings. In accordance with NICE Clinical Knowledge Summaries (CKS) and Royal College of Ophthalmologists guidance, whilst most presentations reflect self-limiting conditions such as viral conjunctivitis or minor subconjunctival haemorrhage, acute clinicians must rapidly identify sight-threatening pathologies that demand immediate emergency intervention.
Systematic Clinical Triage of the Acute Red Eye
When evaluating a patient with an acute red eye, the clinical assessment must immediately establish the presence of cardinal red flag features :
Severe, deep ocular or peri-orbital pain (indicates corneal ulceration, uveitis, scleritis, or acute glaucoma; superficial conjunctivitis causes only grittiness or burning).
True photophobia (characteristically severe in anterior uveitis and keratitis).
Diminished visual acuity (almost never occurs in uncomplicated conjunctivitis or episcleritis).
Haloes around lights (indicative of corneal epithelial oedema in acute angle-closure glaucoma).
Pupillary abnormality (fixed mid-dilated in glaucoma; small, sluggish, or irregular in uveitis).
Ciliary injection (ciliary flush): Violaceous circumcorneal ring of deep episcleral vessel engorgement, contrasting with the diffuse, superficial brick-red injection of conjunctivitis that moves with the conjunctiva and blanches with phenylephrine.
The Acute Red Eye Differential Spectrum
Condition Pain Severity Visual Acuity Pupil Shape & Size Cornea & Anterior Chamber Intraocular Pressure (IOP) Immediate Management
Acute Angle-Closure Glaucoma Severe, excruciating; radiates to head; nausea/vomiting Markedly reduced; rainbow haloes Fixed, mid-dilated, oval (5–6 mm); non-reactive Hazy, steamy cornea; shallow anterior chamber Severely elevated (40–80 mmHg); stony-hard globe Topical pilocarpine 2%, IV acetazolamide 500 mg, topical beta-blockers, bilateral laser iridotomy
Anterior Uveitis (Iritis) Deep, dull, aching; severe photophobia Mildly reduced to normal Small (miotic), sluggish, or irregular (posterior synechiae) Clear or mild haze; keratic precipitates, cells & flare , hypopyon Normal or mildly decreased (rarely elevated) Urgent ophthalmology referral, topical cyclopentolate 1% (mydriatic), topical steroid drops
Bacterial Keratitis Severe sharp pain; foreign body sensation Reduced (especially if central) Normal or reactive miosis Focal white corneal infiltrate/ulcer; hypopyon common Normal or variable Ophthalmic emergency! Hourly fluoroquinolone drops; NEVER eye patch
Herpes Simplex Keratitis Moderate pain; grittiness, watery discharge Normal or mildly reduced Normal Branching dendritic ulcer on fluorescein; reduced corneal sensation Normal Topical aciclovir 3% ointment 5x daily; topical steroids ABSOLUTELY CONTRAINDICATED
Scleritis Severe, deep, boring; radiates to jaw/brow; wakes from sleep Normal or reduced Normal Sclera violaceous/bluish-red; DOES NOT blanch with phenylephrine Normal Urgent ophthalmology referral; high-dose oral NSAIDs, systemic corticosteroids, DMARDs
Episcleritis Mild discomfort, grittiness Normal Normal Localised salmon-pink injection; BLANCHES with phenylephrine 2.5% Normal Artificial tears, cool compresses, oral NSAIDs if symptomatic; self-limiting
Bacterial Conjunctivitis Grittiness, burning; NO deep pain Normal Normal Clear cornea; diffuse injection; copious purulent discharge Normal Self-limiting (clears in 5–7 days); topical chloramphenicol 0.5% drops accelerated recovery
Acute Angle-Closure Glaucoma (AACG)
Acute angle-closure glaucoma is an ophthalmic emergency where mechanical apposition of the peripheral iris against the trabecular meshwork abruptly halts aqueous humour drainage through the canal of Schlemm, precipitating an explosive rise in intraocular pressure.
Risk Factors & Pathophysiology: Predominantly occurs in individuals with an anatomically narrow anterior chamber angle: hypermetropes (long-sighted) , elderly patients with age-related lens thickening, and females of East Asian descent.
Precipitating Triggers: Dilatation of the pupil moves the peripheral iris root into the narrow drainage angle. Triggers include entering a dimly lit room or cinema , emotional stress, and medications with mydriatic properties (anticholinergics such as tropicamide , atropine , tricyclic antidepressants , and nebulised ipratropium bromide delivered via ill-fitting facemask; sympathomimetics).
Clinical Presentation: Rapid onset of excruciating, severe unilateral peri-orbital and ocular pain that radiates across the ipsilateral hemicranium. Patients frequently present with intense frontal headache, nausea, and profuse vomiting, leading to frequent misdiagnoses of acute migraine or intra-abdominal pathology. Visual acuity drops precipitously, accompanied by the classic pathognomonic symptom of coloured rainbow haloes around streetlights .
Physical Signs:
Cornea: Appears hazy, cloudy, or "steamy" (ground-glass appearance) due to corneal epithelial edema.
Pupil: Fixed, mid-dilated (5–6 mm), oval , and completely unreactive to direct or consensual light.
Vascular Injection: Prominent ciliary injection (violaceous circumcorneal flush).
Palpation: Gentle digital palpation through closed upper eyelids demonstrates a stony-hard / rock-hard globe compared to the fellow eye.
Tonometry: Intraocular pressure is markedly elevated, typically 40–80 mmHg (normal physiological range: 10–21 mmHg).
Emergency Medical Management Protocol:
Aim: Rapidly lower IOP to prevent irreversible ischemic necrosis of the optic nerve head and permanent blindness.
Topical Pilocarpine 2% Drops: Parasympathomimetic miotic agent; stimulates pupillary sphincter contraction, pulling the peripheral iris away from the trabecular meshwork to reopen the drainage angle. Instil 1 drop into the affected eye every 15 minutes for 2 doses, then QDS. Critical action: Also instil 1 drop of pilocarpine 1% into the unaffected fellow eye to prevent contralateral angle closure.
Intravenous Acetazolamide 500 mg Stat: Potent carbonic anhydrase inhibitor; rapidly suppresses aqueous humour production by the ciliary body epithelium.
Topical Beta-Blocker (Timolol 0.5% Drops): Suppresses aqueous secretion (contraindicated in severe asthma, COPD, or high-degree heart block).
Topical Alpha-2 Agonist (Apraclonidine 1% Drops): Dual action: decreases aqueous synthesis and enhances uveoscleral outflow.
Systemic Hyperosmotic Agents: Intravenous mannitol 20% (1–2 g/kg over 45 minutes) if IOP remains refractory >50 mmHg after 1–2 hours.
Definitive Treatment: Bilateral Nd:YAG Laser Peripheral Iridotomy (LPI): Once medical therapy clears corneal edema, a laser creates a microscopic full-thickness hole in the superior peripheral iris. This creates a permanent fluid bypass channel connecting the posterior and anterior chambers, curing pupillary block. Both eyes must be treated because the anatomical predisposition is bilateral.
Anterior Uveitis (Acute Iritis / Iridocyclitis)
Anterior uveitis represents acute intraocular inflammation involving the iris and anterior ciliary body.
Systemic Associations: Approximately 50% of cases are associated with the HLA-B27 major histocompatibility antigen: ankylosing spondylitis (young males, morning back stiffness), reactive arthritis (urethritis, arthritis, uveitis: "can't see, can't pee, can't climb a tree"), psoriatic arthritis , and inflammatory bowel disease (Crohn's disease, ulcerative colitis). Non-HLA-B27 associations include sarcoidosis, Behçet's disease, and syphilis.
Clinical Presentation: Deep, dull, aching ocular pain, accompanied by intense photophobia that is characteristically aggravated when light is shone into the unaffected fellow eye ( consensual photophobia , triggered by bilateral consensual pupillary constriction causing traction on the inflamed iris/ciliary body). Visual acuity is mildly blurred, accompanied by watery lacrimation.
Examination Findings:
Vascular Injection: Violaceous circumcorneal ciliary flush .
Pupillary Signs: The pupil is small (miotic) , sluggish, and frequently distorted or irregular due to posterior synechiae (inflammatory fibrinous adhesions binding the pupillary border of the iris to the anterior lens capsule).
Slit-Lamp Hallmarks: Flare (protein leakage into aqueous) and circulating leukocytes ("cells") resembling dust motes in a projector beam; keratic precipitates (inflammatory cell deposits on the lower corneal endothelium); severe inflammation may precipitate a sterile hypopyon (fluid level of layered white blood cells in the anterior chamber).
Emergency Treatment:
Urgent same-day referral to an ophthalmologist.
Topical Cycloplegic / Mydriatic Agent (Cyclopentolate 1% or Atropine 1% Drops): Dual therapeutic mechanism: (1) paralyses the ciliary muscle and pupillary sphincter, abolishing painful ciliary spasm and photophobia; (2) dilates the pupil, pulling the iris border away from the lens, thereby preventing or breaking posterior synechiae.
Topical Corticosteroid Drops (Prednisolone Acetate 1% Drops): Administered intensively (e.g. hourly) to suppress intraocular inflammation.
Caution: Never commence topical corticosteroids until slit-lamp examination definitively excludes herpes simplex dendritic ulceration.
- Microbial Keratitis: Bacterial & Herpetic
- Bacterial Keratitis
Bacterial keratitis is a sight-threatening infectious ulceration of the corneal stroma with loss of the overlying corneal epithelium.
Etiology & Risk Factors: Contact lens wear is the predominant predisposing risk factor (>60% of cases), particularly extended overnight wear or washing lenses in domestic tap water. Pseudomonas aeruginosa is the most notorious pathogen in contact lens wearers, capable of secreting virulent proteases that produce rapid liquefactive stromal necrosis and corneal perforation within 24–48 hours . Other common culprits include Staphylococcus aureus and Streptococcus pneumoniae .
Clinical Presentation: Severe sharp pain, foreign body sensation, marked photophobia, reduced visual acuity, and purulent discharge. Slit-lamp or penlight examination reveals a visible focal white/opaque corneal infiltrate or ulcer with an overlying epithelial defect that stains with fluorescein. A layered hypopyon is frequently present.
Emergency Management Protocol:
Emergency same-day ophthalmological consultation.
Immediate corneal scrapings for Gram stain, microscopy, and culture prior to starting antibiotics.
Intensive Topical Fluoroquinolone Monotherapy: Topical ofloxacin 0.3% or levofloxacin 0.5% eye drops instilled every hour around the clock for the first 24–48 hours.
CRITICAL CONTRAINDICATION — NEVER PATCH A CONTACT LENS ULCER: Applying an eye patch creates a warm, dark, hypoxic, anaerobic chamber that accelerates Pseudomonas proliferation, leading to rapid corneal melting and permanent visual loss.
Herpes Simplex Keratitis (Epithelial Keratitis)
Caused by the reactivation of latent Herpes Simplex Virus Type 1 (HSV-1) within the sensory ophthalmic division (V1) of the trigeminal ganglion.
Clinical Features: Unilateral ocular redness, mild-to-moderate aching discomfort, foreign body sensation, photophobia, and watery lacrimation. A key diagnostic examination sign is reduced corneal sensation (corneal hypoaesthesia) , elicited by gently touching the peripheral cornea with a wisp of sterile cotton.
Pathognomonic Examination Sign: Instillation of fluorescein dye examined under a cobalt blue light reveals a classic branching, arborising dendritic ulcer with linear branching patterns and terminal rounded bulbs that stain bright yellow-green.
Medical Treatment: Topical aciclovir 3% eye ointment applied 5 times daily (or topical ganciclovir 0.15% gel) for 10–14 days.
Caution
Strict Contraindication to Topical Corticosteroids: Topical corticosteroids are ABSOLUTELY CONTRAINDICATED in active dendritic epithelial keratitis. Topical steroids suppress local cell-mediated immunity, permitting unchecked viral replication. This rapidly transforms a delicate branching dendritic ulcer into a massive, destructive "geographical" or amoebic corneal ulcer , culminating in deep stromal melting, secondary bacterial superinfection, and permanent corneal perforation.
Scleritis vs Episcleritis
Episcleritis: Benign, self-limiting inflammation of the superficial episcleral vascular plexus, predominantly affecting young to middle-aged adults (female > male). Manifests with acute mild ocular redness, foreign body grittiness, or burning discomfort. Visual acuity is normal, and there is no severe deep pain . Examination reveals localized salmon-pink sectoral vascular engorgement. The Phenylephrine Test: Instillation of 1 drop of topical phenylephrine 2.5% causes complete blanching of the superficial episcleral vessels within 10–15 minutes, confirming episcleritis. Management requires simple reassurance, artificial lubricants, and oral NSAIDs if symptomatic.
Scleritis: Severe, destructive, sight-threatening chronic granulomatous inflammation of the deep sclera, carrying a >50% association with underlying systemic autoimmune connective tissue diseases, predominantly rheumatoid arthritis , granulomatosis with polyangiitis (GPA / Wegener's), and systemic lupus erythematosus (SLE). Manifests with severe, deep, boring, excruciating ocular pain that characteristically radiates to the temple, forehead, and jaw, and classically wakes the patient from sleep at night . The globe is exquisitely tender to touch. Examination demonstrates a deep violaceous (bluish-red) scleral injection that DOES NOT blanch following topical phenylephrine 2.5% instillation. Complications include scleral thinning ( scleromalacia perforans ), globe perforation, and blindness. Management mandates urgent ophthalmology referral, high-dose oral NSAIDs, systemic oral corticosteroids (prednisolone), and DMARDs / biologic therapies.
Orbital Cellulitis vs Preseptal Cellulitis
The orbital septum—a fibrous sheet of connective tissue originating from the orbital periosteum and inserting into the tarsal plates of the eyelids—acts as a crucial physical barrier separating superficial periorbital tissues from the internal orbital cone.
Diagnostic Feature Preseptal (Periorbital) Cellulitis Orbital Cellulitis (Post-Septal)
Anatomical Site Anterior to the orbital septum (superficial eyelid tissues) Posterior to the orbital septum (within the bony orbital cavity)
Common Aetiology Local skin trauma, insect bite, chalazion, impetigo Spread from adjacent paranasal sinusitis (especially ethmoid sinus)
- Visual Acuity Normal Reduced / Impaired (indicates optic nerve compression)
- Extraocular Eye Movements Full, normal, and painless Painful ophthalmoplegia; restricted motility; diplopia
- Proptosis (Exophthalmos) Absent Present (globe pushed forward by intra-orbital phlegmon/abscess)
- Pupillary Light Reflex Normal; NO RAPD Relative Afferent Pupillary Defect (RAPD) may be present
- Systemic Toxicity Mild; low-grade fever High fever, lethargy, severe systemic toxicity, leukocytosis
Emergency Management Oral co-amoxiclav; close outpatient monitoring Emergency hospital admission, IV broad-spectrum antibiotics, urgent contrast CT of orbits/sinuses
Important
Orbital Cellulitis Complications & Emergency Protocol: Orbital cellulitis is a life- and sight-threatening surgical emergency. Infection spreads rapidly along the valveless ophthalmic venous system into the intracranial vault, causing cavernous sinus thrombosis (characterised by bilateral chemosis, bilateral ophthalmoplegia involving cranial nerves III, IV, and VI, sensory loss across V1/V2, and papilloedema), meningitis, intracranial subdural/brain abscess, and permanent optic nerve ischemia resulting in blindness. Management requires immediate admission under joint ENT and ophthalmology teams, emergency high-resolution contrast-enhanced CT of the orbits, sinuses, and brain, high-dose IV broad-spectrum antibiotics (e.g. IV ceftriaxone + metronidazole or IV co-amoxiclav), and immediate surgical decompression if an orbital subperiosteal abscess or optic nerve compromise is detected.